Integrated Discovery of New Immuno-Molecular Actionable Biomarkers for Tumors With Immune-suppressed Environment

Clinical trial NCT03706625 · COMPLETED

Trial details

NCT number: NCT03706625
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: COMPLETED
Study type: OBSERVATIONAL

Non Hodgkin Lymphoma Non Small Cell Lung Cancer Glioma

Start date: 2018-11-20
Primary completion: 2023-07-06
Enrollment: 201

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.